Identifying Complete Atypical Femur Fractures in Adults with Bisphosphonate Exposure

Endocr Pract. 2024 Mar;30(3):278-281. doi: 10.1016/j.eprac.2023.12.012. Epub 2023 Dec 16.

Authors

Joan C Lo¹, Christopher D Grimsrud²

Affiliations

¹ Division of Research, Kaiser Permanente Northern California, Oakland, California; Department of Endocrinology, the Permanente Medical Group, Kaiser Permanente Oakland Medical Center, Oakland, California. Electronic address: Joan.C.Lo@kp.org.
² Department of Orthopedic Surgery, the Permanente Medical Group, Kaiser Permanente Oakland Medical Center, Oakland, California.

PMID: 38110088
PMCID: PMC10950361 (available on 2025-03-01)
DOI: 10.1016/j.eprac.2023.12.012

No abstract available

Keywords: atypical femur fracture; bisphosphonate; osteoporosis; transverse fracture.

MeSH terms

Adult
Bone Density Conservation Agents* / adverse effects
Diphosphonates / adverse effects
Femoral Fractures* / chemically induced
Femoral Fractures* / diagnostic imaging
Femur
Fractures, Bone*
Humans

Substances

Diphosphonates
Bone Density Conservation Agents

Grants and funding